Open tender · Germany · Contract notice
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-03
Deutsche Rentenversicherung Knappschaft-Bahn-See
Deutsche Rentenversicherung Knappschaft-Bahn-See in Germany is inviting bids for “Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-03”. Bids close on 5 February 2028. To qualify, bidders need at least one similar completed work and EU-Sanktionspaket gegen Russland.
The work
Framework agreement on drug discounts for the active substance Etanercept (ATC-Code: L04AB01) with pharmaceutical companies.
- Contract start date is the 1st of the month following the receipt of the contract and declarations, if received by the 5th of the month.
- Earliest contract start is 01.04.2026, provided the contract and declarations are received by 05.03.2026.
Key facts
- Contract period
- Contracts end automatically on 31.03.2028.
- Evaluation
- This is a framework agreement for joining pre-defined, non-negotiable contracts, not a competitive procurement.
- Price basis
- Fixed, non-negotiable discount rates for all participants.
What it takes to qualify
Worth a closer look
- The tender title is in German ('Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026 -03').
- The submission email address 'openhouse.rabattvertrag2026-03@kbs.de' suggests a specific entity (KBS) but the full name is not provided.
- The tender is for multiple dosage forms (ILO, PEN, IFE, PLI) of the same active substance, but they are presented as separate 'Lots' with identical descriptions.
Experience
- At least 1 similar work — The tender is for a framework agreement on drug discounts for the active substance Etanercept (ATC-Code: L04AB01). No specific prior work experience is mentioned.
- The tender is for a framework agreement on drug discounts for the active substance Etanercept (ATC-Code: L04AB01).
Certifications and registrations
EU-Sanktionspaket gegen RusslandDeclaration on the non-existence of grounds for exclusion (Anlage 3).
Eigenerklärung über das Vorliegen der Zulassung gemäß § 21 Absatz 1 AMGDeclaration on the existence of a marketing authorization in accordance with § 21 paragraph 1 AMG.
Eigenerklärung zum EU-Sanktionspaket gegen RusslandDeclaration regarding the EU sanctions package against Russia.
Pharmazeutischer Unternehmer im Sinne des § 4 Abs. 18 Arzneimittelgesetz (AMG)The tender is only open to pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs as defined by § 4 Abs. 18 AMG.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung zum Nichtvorliegen von Ausschlussgründen (Anlage 3)Declaration on the non-existence of grounds for exclusion.
- Eigenerklärung über das Vorliegen der Zulassung gemäß § 21 Absatz 1 AMGDeclaration on the existence of a marketing authorization in accordance with § 21 paragraph 1 AMG.
- Eigenerklärung zum EU-Sanktionspaket gegen RusslandDeclaration regarding the EU sanctions package against Russia.
- Eigenerklärung über das Vorliegen der Zulassung gemäß § 21 Absatz 1 AMGSimple extract from the commercial register (or comparable proof for non-German EU members) not older than six months.